Inducible T‐cell co‐stimulator (ICOS) and ICOS ligand are novel players in the multiple‐myeloma microenvironmentElena Boggio, Umberto Dianzani, Casimiro Luca Gigliotti et al.|British Journal of Haematology|2021Cited by 15
Anti‐rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activityRiccardo Moia, Riccardo Bruna, Casimiro Luca Gigliotti et al.|Hematological Oncology|2020Cited by 9
ContributorsMona M.A. Abdel-Mottaleb, Esther Moreno, Giuseppina Barrera et al.|Elsevier eBooks|2016Cited by 0